You identify pain points and specific critical needs of disease area strategies and large asset programs that can be addressed with imaging capabilities and solutions, including close interactions with: Study management teams (SMTs), including representatives from Clinical Science, Biomarker Development, Statistical Science, Clinical Operations, Regulatory, and other functions, to assess clinical trial milestones that can benefit from AI/ML-enabled analytics and medical imaging, such as clinical trial design, execution, and analysis. Collaborating closely with The TA Lead in DEPCS and Digital and Patient Centred Outcomes Research leadership, as well as cross-functional teams and external partners, the CVRM Imaging Lead builds multi-year imaging roadmaps that elevate endpoint precision, protects data quality, and drives asset differentiation, improving the probability of technical success within the CVRM pipeline.